MYCO — Mydecine Innovations Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Mydecine Innovations, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.018	2.19	1.5	6.96	0.038
Net Total Accounts Receivable
Net Total Receivables	0.012	0.041	0.205	0.363	0.155
Total Inventory
Prepaid Expenses
Total Current Assets	0.601	2.5	5.22	8.54	0.212
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.076	0.515	0.565	0.01	0
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2.06	9.53	7.58	9.23	0.212
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.207	5.8	2.95	5.82	12.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.231	5.97	7.37	10.5	12.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1.83	3.56	0.211	-1.28	-11.9
Total Liabilities & Shareholders' Equity	2.06	9.53	7.58	9.23	0.212
Total Common Shares Outstanding